Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.010
+0.042 (4.38%)
Aug 5, 2026, 12:35 PM EDT - Market open
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $130.6 million as of August 5, 2026. Its market cap has decreased by -52.18% in one year.
Market Cap
130.60M
Enterprise Value
121.56M
1-Year Change
-52.18%
Ranking
Category
Stock Price
$1.01
ChartMarket Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has decreased from $145.96M to $130.60M, a decrease of -10.52%. That is a compound annual growth rate of -2.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 130.60M | -26.23% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PepGen | 133.50M |
| TuHURA Biosciences | 133.10M |
| Connect Biopharma Holdings | 130.34M |
| Codexis | 129.53M |
| NRx Pharmaceuticals | 127.83M |
| Spruce Biosciences | 127.32M |
| Nautilus Biotechnology | 125.89M |
| Genelux | 125.23M |